GE HealthCare Technologies (GE HealthCare Technologies) ROCE % : 11.11% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GE HealthCare Technologies's annualized ROCE % for the quarter that ended in Mar. 2024 was 11.11%.

GE HealthCare Technologies ROCE % Historical Data

The historical data trend for GE HealthCare Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies ROCE % Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

15.68

15.65

13.02

13.25

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial								12.19	11.51	12.50	12.26	11.11

GE HealthCare Technologies ROCE % Calculation

GE HealthCare Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2903	/	( ( (27539 - 7191)	+	(32454 - 8981) )	/ 2 )
	=	2903	/	( (20348	+	23473)	/ 2 )
	=	2903	/	21910.5
	=	13.25 %

GE HealthCare Technologies's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	2600	/	( ( (32454 - 8981)	+	(32208 - 8859) )	/ 2 )
	=	2600	/	( ( 23473	+	23349 )	/ 2 )
	=	2600	/	23411
	=	11.11 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

GE HealthCare Technologies (NAS:GEHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GE HealthCare Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GEHC:Mexico L0T:Germany

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.

Executives

Kevin Michael O'neill	officer: CEO, PDx	500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott	officer: CEO, Ultrasound	500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro	officer: Chief Financial Officer	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela	officer: CEO, Imaging	500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout	officer: Chief Technology Officer	500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski	officer: Ch. Supply Chain & Serv. Ofc.	500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr	director	GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg	director	100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick	officer: CEO, Patient Care Solutions	500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman	director	21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic	director	ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell	director	8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden	director	C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez	officer: GC & Corporate Secretary	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061